Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BioCorRx (BICX) Accounts Payables (2016 - 2025)

Historic Accounts Payables for BioCorRx (BICX) over the last 17 years, with Q3 2025 value amounting to $12.4 million.

  • BioCorRx's Accounts Payables rose 11825.77% to $12.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.4 million, marking a year-over-year increase of 11825.77%. This contributed to the annual value of $5.6 million for FY2024, which is 1991.0% up from last year.
  • According to the latest figures from Q3 2025, BioCorRx's Accounts Payables is $12.4 million, which was up 11825.77% from $11.8 million recorded in Q2 2025.
  • In the past 5 years, BioCorRx's Accounts Payables registered a high of $12.4 million during Q3 2025, and its lowest value of $2.4 million during Q2 2021.
  • In the last 5 years, BioCorRx's Accounts Payables had a median value of $4.3 million in 2023 and averaged $5.2 million.
  • Per our database at Business Quant, BioCorRx's Accounts Payables soared by 1247.49% in 2021 and then skyrocketed by 12149.46% in 2025.
  • Quarter analysis of 5 years shows BioCorRx's Accounts Payables stood at $3.2 million in 2021, then rose by 22.56% to $3.9 million in 2022, then grew by 18.97% to $4.6 million in 2023, then rose by 19.91% to $5.6 million in 2024, then soared by 122.45% to $12.4 million in 2025.
  • Its last three reported values are $12.4 million in Q3 2025, $11.8 million for Q2 2025, and $10.9 million during Q1 2025.